To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.

We're striving to help more people with chronic spontaneous urticaria—a skin condition marked by hives and distressful itching—return to their daily lives.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Up the stairs to the entrance of the plane they climb: small children with cloudy eyes, teens with thick glasses and practiced squints, adults with dark shades.

Follow Dr. Cobos as he works to provide a patient with a new liver and performs surgery using a tiny video camera.

Novartis opens up a path of research to protect proteins that guard against cancer.

Ambitious scientist accelerates research into African genomic diversity and health challenges with internship

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.